A detailed history of Lmr Partners LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Lmr Partners LLP holds 539,588 shares of SABSW stock, worth $37,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
539,588
Previous 539,588 -0.0%
Holding current value
$37,771
Previous $26,000 19.23%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.04 - $0.08 $6,080 - $12,160
152,000 Added 39.22%
539,588 $26,000
Q3 2022

Nov 14, 2022

BUY
$0.05 - $0.22 $1,461 - $6,432
29,239 Added 8.16%
387,588 $272,000
Q2 2022

Aug 15, 2022

BUY
$0.12 - $0.41 $2,528 - $8,637
21,067 Added 6.25%
358,349 $520,000
Q1 2022

May 16, 2022

BUY
$0.22 - $1.87 $70,616 - $600,236
320,982 Added 1969.21%
337,282 $1.27 Million
Q4 2021

Feb 14, 2022

BUY
$0.95 - $3.0 $15,485 - $48,900
16,300 New
16,300 $127,000

Others Institutions Holding SABSW

About SAB BIOTHERAPEUTICS INC WT EXP


  • Ticker SABSW
  • Sector Healthcare
  • Industry Biotechnology
More about SABSW
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.